^○Kazuki TOKORO¹, Kyosuke UNO^{1, 2}, Shin-ichi MURAMASTU^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan., 2. Laboratory of molecular pharmacology faculty of pharmaceutical science, University of Setsunan, Osaka, Japan, 3. Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke 329-0498, JAPAN, 4. Center for Gene and Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo 113-8564,JAPAN)

^○Fumitaka NAKANO¹, Kyosuke UNO^{2, 3}, Kazuki TOKORO², Hiroki TAKEMOTO¹, Atsumi NITTA^{1, 2} (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan, 3. Laboratory of molecular pharmacology faculty of pharmaceutical sciences, University of Setsunan, Osaka, Japan)

^○Kouhei YOSHINO¹, Yasunori ODA¹, Makoto KIMURA¹, Masahito NANGAKU¹, Yukihiko SHIRAYAMA², Masaomi IYO¹ (1. Department of Psychiatry, Chiba University Graduate School of Medicine, 2. Department of Psychiatry, Teikyo University Chiba Medical Center)

^○Kumi SUZUKI¹, Makiko MIYAMOTO¹, June TOGAMI¹, Daisuke NISHIZAWA², Kazutaka IKEDA², Eizi YOSHIHARA¹, Kazuhiko IWAHASHI^{1, 2, 3} (1. Lab. of Physiology(Project of Neurophysiology),Course of Environmental Health Science, Graduate School of Environmental Health, Azabu University, Kanagawa, Japan, 2. Addictive Substance Project,Department of Psychiatry and Behavioral Science, Tokyo Metropolitan Institute of Medical Science,Tokyo,Japan, 3. Health Administration Center,Azabu University,Kanagawa,Japan)

^○Hiroki FURUIE¹, Masatoshi UKEZONO^{1, 2, 3}, Mitsuhiko YAMADA¹ (1. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. Toyo Rice Corporation, 3. Medical Sciences Innovation Hub Program, RIKEN)